Incorporating Biomarkers Into Cancer and Aging Research
- 20 August 2014
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (24) , 2611-2616
Abstract
The challenge in treating the older adult with cancer is accurately accounting for and adapting management to the heterogeneity in health status of the individual patient. Many oncologists recognize that chronological age alone should not be the determinant when deciding on a treatment regimen. Easily measurable markers that provide an assessment of functional age would be ideal to assess frailty, which may predispose the patient to complications from cancer treatment, including increased toxicity, functional decline, decreased quality of life, and poorer survival. Several categories of potential markers, including chronic inflammatory markers, markers of cellular senescence, and imaging to assess muscle mass to detect sarcopenia, may provide insight into the likelihood of treatment-related complications. This article discusses candidate markers and strategies to evaluate these markers in cancer treatment trials, with the aim of developing a method to assess risk of oncologic outcomes and guide management decisions for both the physician and patient.Keywords
This publication has 79 references indexed in Scilit:
- Relations of a Marker of Endothelial Activation (s-VCAM) to Function and Mortality in Community-Dwelling Older AdultsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Inflammation and Immune System Alterations in FrailtyClinics in Geriatric Medicine, 2011
- Is Telomere Length a Biomarker of Aging? A ReviewThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patientsAge and Ageing, 2010
- Lifestyle impacts on the aging‐associated expression of biomarkers of DNA damage and telomere dysfunction in human bloodAging Cell, 2010
- Leukocyte Telomere Length Is Associated with Disability in Older U.S. PopulationJournal of the American Geriatrics Society, 2010
- Inflammatory networks during cellular senescence: causes and consequencesTrends in Molecular Medicine, 2010
- Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human agingAging Cell, 2009
- Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and diseaseProceedings of the National Academy of Sciences, 2008
- Telomeres shorten during ageing of human fibroblastsNature, 1990